MED — Medartis Holding AG Income Statement
0.000.00%
- CH₣913.59m
- CH₣904.33m
- CH₣224.83m
- 76
- 10
- 92
- 65
Annual income statement for Medartis Holding AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 128 | 160 | 183 | 212 | 225 |
Cost of Revenue | |||||
Gross Profit | 106 | 134 | 149 | 168 | 179 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 125 | 149 | 185 | 204 | 217 |
Operating Profit | 3.13 | 11.1 | -1.92 | 7.75 | 7.87 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.26 | 8.29 | -7.14 | 1.79 | 2.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.944 | 6.84 | -5.78 | 0.62 | 3.53 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.944 | 6.84 | -5.78 | 0.62 | 3.53 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.944 | 6.84 | -5.78 | 0.619 | 3.53 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.015 | 0.616 | -0.093 | -0.058 | 1.55 |
Dividends per Share |